Expert in Addiction Treatment
The O’Neil Long Acting Naltrexone Implant, otherwise known as the OLANI, was developed by Dr. George O’Neil. Dr. O’Neil recognized that in Australia, like in the United States, there were only two common treatments available for people who wished to be free of opiate addictions. One involved the use of methadone or buprenorphine, drugs which helped people “manage” their addictions through a regular dose of a synthetic opioid, keeping them dependent. The other was to go “cold turkey”, i.e. to abstain. He wasn’t comfortable with either approach.
When Dr. O’Neil began his search for alternatives the only form of naltrexone available was the daily dose. He witnessed the benefits that drug and alcohol addicts received when taking a regular dosage of naltrexone, however he sought a solution to the problems associated with patients failing to take their daily oral naltrexone pills. Daily oral naltrexone worked well as an opiate antagonist (though at a higher dose than is necessary), but relapses were still common because it was too easy to simply quit taking it.
When Dr. O’Neil first began his research, implants had already been developed in both Russia and the United States that released doses of Naltrexone over a sixty day period. The variability of the amount of naltrexone can create negative side effects, such as anxiety and depression. While Dr. O’Neil admired these innovative implants, he believed that for recovering addicts to be successful, the implant would need to last longer than sixty days and he wanted to find a way to eliminate those side effects. This is why Dr. O’Neil developed the OLANI. Working with the same polymers used to make biodegradable surgical screws Dr. O’Neil made an implant that offers a much steadier low dose for five times longer than other implants available on the market.
Latest & Safest Treatment Technology
The O’Neil Long Acting Naltrexone Implant has been shown to last over 5 times the amount of time as previous implants, with a higher accuracy of steady doses. Dr. O’Neil’s implant has now been used in over 8,000 patients to help combat opiate, opioid, alcohol, cocaine, methamphetamine, and poly-drug addictions.
Dr. O’Neil and his team of physicians make a small incision below the belt line of each patient, and carefully place a O’Neil Long Acting Naltrexone Implant beneath each patients skin, while their patient is under local anesthetics. Once implanted, the OLANI will begin to break down naltrexone, releasing a steady dosage into the body for a year. Naltrexone is effective in preventing relapses by binding to the opiate receptors in the body, and by blocking opiates from having an effect. The implant usually reduces drug cravings drastically, while making drug usage unfulfilling and lacking the pleasure that used to come with drug usage.